OUR KEY OBJECTIVES

OUR KEY OBJECTIVES IN ACCORDANCE WITH THE WORLD HEALTH ORGANIZATION (WHO) GLOBAL DIABETES COMPACT

In 2021, the World Health Organization (WHO) launched the Global Diabetes Compact. The Compact aims to reduce the risk of diabetes and ensure that people around the world have access to equitable, comprehensive, affordable and quality treatment and care.

Throughout the foundation of the Compact, eight key areas were identified through expert discussions and collaboration with key stakeholders, including the United Nations (UN) agencies, insulin and diabetes healthcare technology providers, academia, civil society, and people with life experience with diabetes mellitus.

Gorbiopharm fully supports the Compact and strives to contribute to the observance of the principles and guidelines of the WHO.